Transcript Highlights:

• members, is does the government have the right by a mere simple majority vote to put medicines and drugs
• government have the right by simple majority to decide that they can put an FDA regulated and approved drug
• What we argue is that we can't force you to have it or any other drug that some simple majority may believe
• entered these unlawfully and moved into these buildings, occupying them for purposes of trafficking drugs
• the disclosures and the removal of the persons encounter criminal activities such as trafficking. drugs

Bills: HB 1500 , HJR 7 , HJR 112 , HB 34 , HB 133 , HB 112 , HB 119 , HB 128 , HB 130 , HB 132 , HB 2756 , HB 166 , HB 406 , HB 186 , HB 271 , HB 331 , HB 380 , HB 1583 , HB 1584 , HB 1819 , HB 621 , HB 303 , HB 552 , HB 366 , HB 463 , HB 1211 , HB 1327 , HB 1461 , HB 923 , HB 1760 , HB 2043 , HB 2467 , HB 5333 , HB 5265 , HB 1592 , HB 1576 , HB 1552 , HB 2018 , HB 3511 , HB 1781 , HB 2013 , HB 2340 , HB 2349 , HB 2508 , HB 2970 , HB 2520 , HB 865 , HB 2851 , HB 3385 , HB 3336 , HB 3529 , HB 3309 , HB 1127 , HB 1232 , HB 1397 , HB 4236 , HB 1804 , HB 1926 , HB 4041 , HB 1965 , HB 1964 , HB 2679 , HB 2730 , HB 3698 , HB 3699 , HCR 77 , HB 3354 , HB 163 , HB 201 , HB 272 , HB 333 , HB 405 , HB 519 , HB 569 , HB 654 , HB 694 , HB 791 , HB 1006 , HB 1136 , HB 1240 , HB 1266 , HB 1275 , HB 1437 , HB 1532 , HB 1675 , HB 1842 , HB 1868 , HB 1888 , HB 1894 , HB 1943 , HB 1990 , HB 2029 , HB 2061 , HB 2286 , HB 2523 , HB 2622 , HB 2626 , HB 2652 , HB 2692 , HB 2842 , HB 2885 , HB 2914 , HB 3016 , HB 3096 , HB 3129 , HB 3248 , HB 3251 , HB 3255 , HB 3479 , HB 3611 , HB 3623 , HB 3701 , HB 3724 , HB 3803 , HB 3804 , HB 3805 , HB 3806 , HB 3810 , HB 3816 , HB 3832 , HB 3887 , HB 4127 , HB 4129 , HB 4130 , HB 4131 , HB 4163 , HB 4187 , HB 4229 , HB 4238 , HB 4454 , HB 4588 , HB 4643 , HB 4736 , HB 4738 , HB 4739 , HB 4945 , HB 5015 , HB 5616 , SB 767 , SB 1619 , SB 1738 , HJR 5 , HJR 2 , HB 1399 , HB 388 , HB 114 , HB 205 , HB 2789 , HB 2791 , HB 499 , HB 2960 , HB 3163 , HB 3135 , HB 2427 , HB 1672 , HB 1722 , HB 2618 , HB 879 , HB 1126 , HB 4134 , HB 3513 , HB 1445 , HB 1893 , HB 1734 , HB 3229 , HB 3306 , HB 1276 , HB 3516 , HB 4145 , HB 1585 , HB 4810 , HB 2558 , HB 2742 , HB 1695 , HB 33 , HB 144 , HB 109 , HB 103 , HB 148 , HB 3809 , HB 2217 , HB 220 , HB 2421 , HB 2363 , HB 421 , HB 2455 , HB 3711 , HB 2559 , HB 2775 , HB 3126 , HB 3666 , HB 3595 , HB 3260 , HB 3376 , HB 3826 , HB 3770 , HB 1831 , HB 2614 , HB 3113 , HB 322 , HB 431 , HB 869 , HB 1203 , HB 1244 , HB 1875 , HB 1950 , HB 2152 , HB 2341 , HB 2809 , HB 2856 , HB 3012 , SB 1415 , SB 1058 , SB 487 , SB 1499 , SB 513 , SB 1697 , SB 1197 , SB 1437 , SB 1809 , SB 836 , SB 1879 , SB 1145 , SB 963 , SB 1038 , SB 1147 , SB 914 , SB 711 , SB 1409 , HB 3707 , HB 589 , HB 1360 , HB 2337 , HB 2391 , HB 718 , HB 23 , HB 2436 , HB 1500 , HJR 7 , HJR 112 , HB 34 , HB 133 , HB 112 , HB 119 , HB 128 , HB 130 , HB 132 , HB 2756 , HB 166 , HB 406 , HB 186 , HB 271 , HB 331 , HB 380 , HB 1583 , HB 1584 , HB 1819 , HB 621 , HB 303 , HB 552 , HB 366 , HB 463 , HB 1211 , HB 1327 , HB 1461 , HB 923 , HB 1760 , HB 2043 , HB 2467 , HB 5333 , HB 5265 , HB 1592 , HB 1576 , HB 1552 , HB 2018 , HB 3511 , HB 1781 , HB 2013 , HB 2340 , HB 2349 , HB 2508 , HB 2970 , HB 2520 , HB 865 , HB 2851 , HB 3385 , HB 3336 , HB 3529 , HB 3309 , HB 1127 , HB 1232 , HB 1397 , HB 4236 , HB 1804 , HB 1926 , HB 4041 , HB 1965 , HB 1964 , HB 2679 , HB 2730 , HB 3698 , HB 3699 , HB 3354 , HB 163 , HB 201 , HB 272 , HB 333 , HB 405 , HB 519 , HB 569 , HB 654 , HB 694 , HB 791 , HB 1006 , HB 1136 , HB 1240 , HB 1266 , HB 1275 , HB 1437 , HB 1532 , HB 1675 , HB 1842 , HB 1868 , HB 1888 , HB 1894 , HB 1943 , HB 1990 , HB 2029 , HB 2061 , HB 2286 , HB 2523 , HB 2622 , HB 2626 , HB 2652 , HB 2692 , HB 2842 , HB 2885 , HB 2914 , HB 3016 , HB 3096 , HB 3129 , HB 3248 , HB 3251 , HB 3255 , HB 3479 , HB 3611 , HB 3623 , HB 3701 , HB 3724 , HB 3803 , HB 3804 , HB 3805 , HB 3806 , HB 3810 , HB 3816 , HB 3832 , HB 3887 , HB 4127 , HB 4129 , HB 4130 , HB 4131 , HB 4163 , HB 4187 , HB 4229 , HB 4238 , HB 4454 , HB 4588 , HB 4643 , HB 4736 , HB 4738 , HB 4739 , HB 4945 , HB 5015 , HB 5616 , SB 767 , SB 1619 , SB 1738 , HCR 77

Transcript Highlights:

• We have a presentation today by the Medicare Advantage Prescription Drug Contracts and related marketing
• And so the Medicare Advantage prescription drug plan allowed them to reinstate that pharmacy benefit.
• Before the Inflation Reduction Act, the federal government subsidized Medicare drug coverage through
• So as manufacturers picked up more of the costs of the drugs and people were utilizing more drugs, more
• And so as manufacturers picked up more of the costs of the drugs and people were utilizing more drugs

Committee: All ALC-STATE INSURANCE PROGRAMS OVERSIGHT SUBCOMMITTEE

Transcript Highlights:

• I’m pleased to report that each of our institutions within the Texas Tech system are ahead of schedule
• Our general education curriculum review is ahead of schedule, with certification before January 2027.
• Anderson is home to the world's largest cancer clinical trials program, and 70 percent of all cancer drugs
• Clinical trials are research studies that evaluate new drugs or treatments to make sure they're safe
• spectrum, it's intellectual property that we are in the process of patenting that might turn into a drug

Summary: The Senate Committee on Higher Education met with a quorum, adopted its interim rules on a 6-0 vote, and heard opening remarks from members and staff introductions. The chair emphasized higher education’s role in workforce development and noted a Legislative Budget Board survey issue that was resolved after a community college initially did not respond because the survey was marked optional. The committee then focused on monitoring implementation of Senate Bill 37, which governs public higher education boards, curriculum review, faculty senates/councils, training for regents, and the ombudsman office. Testimony from Chancellor Brandon Creighton of Texas Tech, Commissioner Wynn Rosser, UNT Chancellor Michael Williams, and Ombudsman Brandon Simmons described how SB 37 is being implemented. They said boards now have stronger authority, faculty senates are advisory, and institutions are reviewing general education curricula and other programs for rigor, relevance, and workforce value. Rosser said the statewide advisory committee is reviewing the core curriculum and board training requirements are being administered, while Simmons reported the ombudsman office has received 73 complaints, opened two investigations, and expects a third, with many complaints outside its jurisdiction or harassing in nature. Members questioned witnesses about transfer credits, board training content, auditing, conflicts of interest, curriculum decisions, and whether any institutions were missing deadlines. Rosser said non-transferable credits have declined since reporting began under earlier law, and that the most common reason is courses outside degree requirements. Witnesses said they were not aware of institutions missing the SB 37 review deadlines. Senators also raised concerns about an appearance of impropriety in a Texas Tech-related matter and about whether a Dred Scott case should be taught in law school, with Creighton saying the curriculum review process did not prohibit teaching Supreme Court cases and that he would follow up. Later testimony from University of Houston, Texas State, UT, and Texas A&M system officials said their systems had updated policies, abolished prior faculty senates, created compliant advisory councils, and completed or were completing core curriculum reviews and related governance changes.

Transcript Highlights:

• therapy to establish a therapy initiative when the Department of Health provides for clinical studies, drug
• provides relative to health insurance and formulary placement, cost-sharing obligations for certain drugs
• Louisiana-specific medical claims database, uses data to monitor and adjust workers’ compensation fee schedules
• Food and Drug Administration requires an ingredient be named on a food label, the federal government
• that I reminded you that the Senate has gone through all of the House bills that they had on their schedule

Bills: HR320 , HR321 , SCR55 , SCR69 , SCR75 , SCR77 , SCR78 , SCR79 , SB259 , SB295 , SB312 , SB348 , SB444 , SB485 , HR73 , HR118 , HR144 , HR196 , HR237 , HR249 , HR260 , HR267 , HR272 , HR278 , HCR85 , HCR100 , HCR105 , HCR107 , HCR114 , HR245 , SCR5 , SCR29 , SCR33 , SCR37 , SCR63 , SCR30 , SCR40 , HB62 , HB193 , HB210 , HB220 , HB246 , HB364 , HB420 , HB475 , HB584 , HB622 , HB772 , HB784 , HB949 , HB953 , HB1043 , HB1070 , HB1092 , HB1134 , HB1162 , HB1176 , HB1196 , HB1214 , HB119 , HB129 , HB233 , HB283 , HB538 , HB789 , HB850 , HB870 , HB1236 , HB1241 , HB54 , HB137 , HB321 , HB368 , HB386 , HB414 , HB431 , HB552 , HB555 , HB578 , HB590 , HB593 , HB618 , HB638 , HB670 , HB692 , HB707 , HB708 , HB715 , HB718 , HB732 , HB741 , HB748 , HB776 , HB796 , HB807 , HB822 , HB848 , HB856 , HB887 , HB888 , HB917 , HB921 , HB1082 , HB1243 , HB1246 , HB378 , HB509 , HB1090 , HB1259 , SB80 , SB131 , SB143 , SB251 , SB254 , SB279 , SB367 , SB384 , SB388 , SB389 , SB398 , SB408 , SB431 , SB468 , SB469 , SB496 , SB4 , SB52 , SB57 , SB83 , SB145 , SB152 , SB194 , SB276 , SB319 , SB333 , SB448 , SB450 , SB465 , SB484 , SB501 , SB509 , SB149 , HR168 , HB463 , HB998 , SB123 , SB353 , SB479 , SB495 , SB82 , SB97 , SB283 , SB326 , SB518 , SB197 , SB268 , HB901 , HR20 , HR74 , HCR65 , HCR71 , HCR98 , HB284 , HB306 , HB341 , HB366 , HB393 , HB458 , HB577 , HB603 , HB605 , HB614 , HB625 , HB646 , HB733 , HB752 , HB773 , HB798 , HB911 , HB955 , HB996 , HB1035 , HB1069 , HB1113 , HB1140 , HB1180 , HB1191 , HB1240 , HB1255 , SB89 , HB74 , HB134 , HB258 , HB359 , HB468 , HB956 , HB1117 , SB29 , SB42 , SB43 , SB78 , SB208 , SB217 , SB274 , SB300 , SB341 , SB379 , SB382 , SB387 , SB401 , SB441 , SB449 , SB487

Summary: The House was called to order, a quorum was established, and the meeting opened with prayer and the Pledge of Allegiance. Members also observed several personal privileges and recognitions, including International Preeclampsia Awareness Month, the Hudson Cup award presentation to Rep. John Illg Jr., recognition of the Delcambre Shrimp Festival Queen, and a visit from U.S. Sen. John Kennedy. The chamber also received Senate messages, conference committee appointments, enrolled reports, and a conference report on SB 483 dealing with psychedelic-assisted therapy, which was laid over. The House then moved through a long series of concurrence and rejection votes on Senate amendments to House bills. Among the measures concurred in were bills affecting the Louisiana Women’s Policy Research Commission, the Louisiana Sickle Cell Commission, child exploitation reporting on covered platforms, the Children’s Cabinet Advisory Board, DCFS background checks, AI disclosure in health care, foster care placement and related terminology, criminal history record confidentiality, parish court jurisdiction, court costs, developmental disability office renaming, insurance claims and contractor licensing, Medicare Advantage coverage, colorectal cancer screening, health facilities, highway memorial designations, jury compensation, school employee protections, juvenile court fees, off-road vehicle seizure, residential property insurance cancellation, child support enforcement, and several others. The House rejected Senate amendments on bills including ethics retroactivity, sex offender registration notification, plumbers licensing, and health insurance formulary placement, sending some to conference. Several bills were finally passed, including measures on obstructing public passages with motorized vehicles, class six injection well hearings, arson of religious buildings, wearing masks while committing felonies, professional board attorney fees, bulletproof vests for peace officers, critical infrastructure protection from foreign adversaries, debit card surcharges, electronic stock certificates, watershed restoration funding, and innovation economic development pilot hubs. The innovation hub bill drew extensive debate over no-bid contracting, transparency, and the role of elected versus unelected bodies; an amendment to limit contracting authority to parish governing authorities was withdrawn, and the bill later proceeded to final passage after extended floor discussion. The House also took up and passed or concurred in multiple other bills and resolutions, with recorded votes ranging from unanimous to divided on a few measures.

Transcript Highlights:

• Food and Drug Administration. Protect women, do better, stop giving them these harmful drugs.
• There were no differences in rates of drug use, drug sales, or infectious diseases by the counties that
• Glenn Backus for Drug Policy Alliance, proud co-sponsor.
• Norma Palacios with the Drug Policy Alliance in support.
• I think we wanted to create less drug addicts.

Committee: House Health

Summary: The Assembly Health Committee met on April 8 and heard a long series of bills focused largely on reproductive health, public health, housing, and health workforce issues. Early items included AB 54 and AB 260, both aimed at protecting access to medication abortion in California by shielding providers, manufacturers, pharmacies, and others from liability and by preserving access through telehealth and other delivery methods. Supporters, including the Attorney General’s office, Planned Parenthood, Black Women for Wellness, and other reproductive justice groups, argued the bills were needed to preserve access after Dobbs and amid federal threats. Opponents from the California Family Council and California Catholic Conference argued the measures removed safeguards and promoted unsafe abortion access. Both bills were moved forward on committee votes. The committee also heard AB 551, which would create a pilot program to help emergency departments provide evidence-based reproductive health services, and AB 309, which would remove sunset dates on laws allowing pharmacists to sell syringes without a prescription and clarifying that possession of sterile syringes for personal use is not a crime. AB 551 drew support from emergency physicians and reproductive health organizations, while opponents said it would expand abortion access without adequate safeguards. AB 309 was supported by public health, pharmacy, and harm-reduction groups as a proven HIV and hepatitis prevention tool; the California Narcotic Officers Association opposed it. AB 309 was approved, while AB 551 was also advanced. Other measures advanced included AB 536, which would preserve colorectal cancer screening coverage if federal preventive-care rules are disrupted; AB 804, which would make housing support services a Medi-Cal benefit and seek federal matching funds; AB 594, which would protect students from being charged for school health insurance after they withdraw and require notice of premium increases; AB 836, which would study and expand California’s midwifery education pipeline; AB 1418, which would require reporting on health coverage trends for eligible employees; and AB 1500, which would expand and preserve abortion.ca.gov as a trusted reproductive health information resource. Each drew supportive testimony from sponsors, health care providers, and advocacy groups, with some opposition to AB 1500 arguing the state should provide broader women’s health information rather than an abortion-focused site. Most of these bills were moved out of committee on party-line or near-party-line votes, and several measures were placed on call before final roll calls.

Transcript Highlights:

• We're told to use drugs. Don't get me wrong, drugs are valuable.
• We love our drugs in this country. We swallow more drugs than anybody.
• We're told to use drugs. Don't get me wrong, drugs are valuable.
• We're told to use drugs. Don't get me wrong, drugs are valuable.
• </c> to prescribe drugs? to prescribe drugs?

Summary: The task force met for its third meeting, approved the minutes, and heard testimony from Dr. Jack on behalf of the American Beverage Association and Kentucky Beverage Association. Dr. Jack argued that the “totality of the science” supports low- and no-calorie sweeteners as safe and useful tools for reducing sugar and calories, citing FDA and other domestic and international reviews, clinical trials, and the FDA’s recent healthy-label rule. He also described the industry’s transparency efforts, including a “Good to Know” database compiling ingredient and safety information, and said the beverage industry has voluntarily worked to offer more choices with less sugar. Members questioned him about whether beverage ingredients are restricted in other countries, possible health effects beyond weight and cancer, concerns about metabolic issues and gut microbiome effects, whether sweeteners are addictive, and why companies do not simply remove sweeteners. Dr. Jack responded that most ingredients are permitted in many jurisdictions, that broad food-safety reviews have looked at multiple endpoints and found the ingredients safe, that the gut microbiome is still being studied, and that recent clinical evidence does not show increased sweetness preference. He also said business decisions about formulations are up to companies and noted that cane sugar and high-fructose corn syrup are metabolically similar. The committee also discussed consumer apps and ingredient-scoring tools; Dr. Jack said the industry’s website presents facts without interpretation and is based on food-safety agency assessments. At the end of his testimony, the chair accepted additional fact sheets for the committee. The meeting then moved on to introduce Dr. Gary Huber, who began testimony by emphasizing integrative medicine, metabolic syndrome, and the role of diet, exercise, sleep, and stress in health, but his full presentation was not included in the excerpt.

Transcript Highlights:

• Obviously, there's a whole list of how those drugs are now.
• Do we have any sort of impact for how that will affect our list of drugs?
• Do we have any sort of impact for how that will affect our list of drugs?
• This is the February 2026 medical drug recommendations.
• This is the February 2026 medical drug recommendations.

Committee: All ALC-STATE INSURANCE PROGRAMS OVERSIGHT SUBCOMMITTEE

Summary: The State Insurance Programs Oversight Subcommittee met to review and approve several State Board of Finance actions related to employee benefits and pharmacy coverage. Grant Wallace, Director of the Employee Benefits Division and Office of Property Risk, presented a $280,000 Boston Consulting Group contract to help develop a third-party administration RFP, and the committee approved it. The committee then considered pharmacy formulary recommendations for December 2025, January 2026, and February 2026, along with February 2026 medical drug recommendations. Across the formulary items, Wallace explained that some drugs were being removed from prior authorization requirements, some were being updated to reflect FDA guidance or dosage changes, and others were being left not covered because lower-cost alternatives already exist or clinical evidence was insufficient. Notable changes included removing Skyrizi and Renvoke from the pharmacy formulary in favor of lower-cost biosimilars, adding certain generics, and adding a subcutaneous version of Keytruda for faster administration. The committee approved each set of recommendations by motion and voice vote. Members also raised broader questions about the impact of new drug-pricing programs such as Trump RX, Cost Plus, and other manufacturer discount efforts, as well as concerns about PBM oversight and whether Navitus is complying with state law. Wallace said the department is still studying those issues and working with Navitus to assess pricing opportunities and compliance. Senator Boyd also asked about whether affiliated pharmacies are being paid more than independent pharmacies, noting he had not received a prior response; Wallace was asked to follow up. The meeting concluded with no further business and adjournment.

Transcript Highlights:

• Food and Drug Administration might cause concern as well. There might be some drugs.
• That's what you're doing by taking off that abortion-inducing drug.
• Food and Drug Administration, that might cause concern as well. There might be some drugs.
• That's what you're doing by taking off that abortion-inducing drug.
• But there are other drugs, you know, what types are going to be used as this, other drugs, you know,

Committee: House Crime and Public Safety

Transcript Highlights:

• for quite some time now, and we should act to try to quell the nearly double violations for illegal drugs
• for quite some time now, and we should act to try to quell the nearly double violations for illegal drugs
• </c><00:01:03.519><c> that</c> violations for um uh illegal drugs that violations for um uh illegal drugs
• </c> the drugs especially the synthetic drugs the drugs especially the synthetic drugs that<00:09:10.680
• </c><00:10:37.279><c> lead</c> the drugs lead the drugs lead mhler<00:10:39.040><c> yeah</c><00:10:39.200

Summary: The committee took up House File 327, which would increase penalties for introducing contraband into correctional facilities, especially drugs and other dangerous items sent through the mail or brought in by outside actors. Representative Ingan described the bill as a response to a sharp rise in violations and staff exposures in DOC facilities, arguing that stronger felony penalties are needed to deter people from sending in illicit substances. The bill was laid over for possible inclusion in the committee omnibus because it has a fiscal note. The committee adopted the DE1 author’s amendment after Representative Ingan explained it was intended to clarify language that could otherwise create a catch-22 for people arrested or booked into jail who already have contraband on them. Members then raised concerns about the breadth of the bill, including overlap with an existing DOC statute and the possibility that the language could sweep in incarcerated people in situations involving prescription medication or minor exchanges. House nonpartisan staff and members suggested the DOC provisions should be reconciled with existing law before moving forward, and some suggested narrowing the bill to focus more specifically on jails. Sheriff Brad Wise of the Minnesota Sheriffs Association testified in support, saying contraband in jails threatens staff, inmates, visitors, and administrators and that current penalties are not enough to deter smuggling. Commissioner Paul Schell of Corrections also testified, noting that DOC already has a separate statute with a higher felony penalty for certain contraband, described the department’s mail-scanning contractor process, and said it has reduced suspected drug incidents by about two-thirds. An A2 amendment tied to medication intake practices was offered by Representative Curran but then withdrawn after discussion, with members agreeing the issue of medication access in facilities should be handled separately.

Transcript Highlights:

• Members of the committee, Gray Gardner, on behalf of the Drug Policy Alliance.
• Longer sentences... ...of drugs or overdose deaths.
• Because people who sell or share drugs are often themselves people who use drugs and are often experiencing
• Sir, your son, do you feel that he would be selling this drug after he took it?"
• She wasn't looking to sell drugs or anything.

Summary: The Assembly Standing Committee on Public Safety met with several bills on the agenda, beginning with AB 1741 by Assembly Member Pacheco, which would allow felony prosecution of sexual battery committed during a residential break-in. Supporters, including Riverside County prosecutors and victim services staff, said current law leaves some home-invasion sexual assaults as misdemeanors when intent to commit another felony cannot be proven; opponents from public defender and civil liberties groups argued the bill was unnecessary, vague, and overbroad. After discussion, the committee passed AB 1741 to Appropriations as amended. The committee then heard AB 1701 by Assembly Member DeMaio, which would bar recall and resentencing for juveniles convicted of school shootings. Supporters framed it as a narrow public-safety measure in response to the Santana High School shooting and the potential resentencing of the shooter; opponents argued it was overly broad, ineffective as deterrence, and inconsistent with juvenile rehabilitation principles. The committee ultimately voted the bill out to Appropriations, but it later failed on the final roll call when members added on their positions. AB 1743 by Assembly Member Wix proposed allowing local governments, state agencies, and higher education institutions to request firearm trace data from DOJ for research and policy purposes. Supporters said the data could help identify trafficking patterns and inform evidence-based gun violence prevention, while opponents said trace data only shows the first lawful retail sale and could mislead policymakers or burden DOJ. The bill was passed to Appropriations. AB 1716 by Assembly Member Stefani, supported by UC and victim advocates, would let CalVCB reimburse tuition costs for college students whose education is disrupted by sexual violence; it passed to Appropriations after a strong debate over victim compensation. AB 1667 by Assembly Member Burner, adding fentanyl to the serious felony list for furnishing to a minor, also passed after emotional testimony from a bereaved parent and law enforcement support, despite opposition from drug policy and civil liberties groups. The committee adopted a consent calendar including AB 1549, AB 1681, AB 1723, and AB 1737, while AB 1538 and AB 1727 were pulled by their authors. In the final tally, AB 1701 and AB 1723 failed on the floor add-on roll call, while AB 1716, AB 1741, AB 1743, and AB 1667 advanced.

Transcript Highlights:

• An act to conduct a public health study of synthetic drugs in the Commonwealth.
• Fluoride is a prescription drug. It provides little, if any, benefit.
• Fluoride is a prescription drug. It provides little, if any, benefit.
• such as anesthetics, steroids, antipsychotics, anti-cancer drugs, diet drugs, digestive support, Antibiotics
• , anti-cancer drugs, diet drugs, digestive support, statins, Celebrex and Vioxx, Prozac-type drugs, some

Committee: Joint Joint Committee on Public Health

Summary: The Joint Committee on Public Health held a hearing focused on children’s health, disease prevention, screening, treatment, and pharmacy-related bills. The chair explained that the session was for public testimony only, with no votes or decisions taken that day, and outlined the three-minute limit for individual testimony. The committee then heard testimony on a range of bills, including H. 2413 on adding electromagnetic sensitivity to the state’s MAVEN registry, S. 1508 and H. 2433 on creating an amputation prevention task force, H. 2535 and S. 1551 on establishing a naloxone purchase trust fund, S. 1635 on authorizing pharmacists to provide opioid use disorder treatment, H. 2385 on creating a special commission on avian influenza, and S. 1497 on patient safety and non-FDA-approved compounded drugs. Testimony on H. 2413 came largely from advocates and individuals who described electromagnetic sensitivity as a real health condition and argued that adding it to the registry would improve data collection, provider education, and public awareness. Testimony on the amputation prevention task force bills came from the American Diabetes Association and podiatry groups, who said diabetes-related amputations are often preventable, disproportionately affect people of color, and could be reduced through earlier screening, better care coordination, and improved insurance coverage for preventive foot care. On the naloxone trust fund bills, a representative, emergency physician, and nurse testified that hospitals often cannot reliably send overdose patients home with naloxone because of billing and reimbursement barriers, and that a bulk-purchase fund would expand access at no added cost to payers or providers. The committee also heard strong support for S. 1635 from pharmacists and public health researchers, who said community pharmacists could safely initiate and maintain buprenorphine treatment and help close gaps in opioid use disorder care. On H. 2385, a local board of health chair supported a special commission on avian influenza, citing gaps in emergency preparedness and the need for clearer coordination across agencies. On S. 1497, a pharmacy representative opposed restrictions on compounded drugs from outsourcing facilities, warning that changes could reduce access to life-saving medications and harm patient safety. No votes or formal actions were taken during the hearing.

Transcript Highlights:

• that are at risk of drug market failure here in California.
• or new drugs? Yeah, we've been doing an analysis of target drugs.
• Additionally, there is this five million dollars for additional target drugs.
• pricing and to address the high cost of prescription drugs.
• from drug manufacturers, since they set the price.

Transcript Highlights:

• Access to FDA-approved drugs that are safe and effective.
• Drug companies often keep these drug prices high by setting their own list prices and then offering copay
• Companies also use drug coupons to increase drug sales for a particular brand-name drug and to steer
• It's directly between the patient and the pharmacy and the drug company.
• That had been brought up versus, you know, perhaps a lower-cost drug.

Committee: Senate Health

Transcript Highlights:

• compensation by one additional day for parish elections and one additional day for presidential, regularly scheduled
• I hadn't asked the chairman to schedule it because it wasn't as important as this, although it was important
• We're on a time schedule and need to be in other committees.
• bad now, considering the level of poverty in our state, the domestic violence, the gun violence, the drugs

Committee: Senate Finance

Summary: The committee first heard Senate Bill 135, which would redirect a portion of wagering dedications from the sports fund to the Louisiana Early Childhood Education Fund and remove a cap affecting that funding stream. The author and staff explained the amendment was designed to avoid any impact on the State General Fund while increasing support for early childhood education. The committee adopted the amendment and reported the bill favorably as amended. Senate Bill 202, from the Secretary of State’s office, would increase the number of compensated days for parish board of election supervisors to cover additional election-related duties. Secretary Landry and election officials testified that the change was needed because supervisors now perform more work, including ballot tabulation, machine sealing, and verification tasks. The committee adopted technical and appropriation-related amendments and reported the bill favorably as amended. The committee then took up several health and human services bills. Senate Bill 155 would require insurance coverage for medically necessary dental procedures needed before cancer treatment; testimony from medical and dental professionals emphasized that untreated dental problems can delay chemotherapy or radiation and worsen outcomes. After adopting amendments to narrow the fiscal impact, the bill was reported favorably as amended, with discussion of a possible subject-to-appropriation amendment to be worked out later. Senate Bill 237, a major DCFS reform bill, drew extensive testimony and debate over child welfare oversight, mandatory reporter training, law enforcement coordination, and the bill’s large fiscal note. The committee adopted amendments, including a subject-to-appropriation provision, and reported the bill favorably as amended after emotional testimony from supporters and former DCFS employees. The committee also advanced Senate Bill 465 on prompt-pay insurance reform after an amendment reduced the fiscal note to zero; Senate Bill 261 on unclaimed property after a substitute bill was adopted; Senate Bill 295 on expanded coverage for traumatic brain injury rehabilitation after amendments narrowed the mandate and added subject-to-appropriation language; Senate Bill 157 providing six weeks of paid parental leave for K-12 educators and staff, also subject to appropriation; Senate Bill 276 requiring bail bond producers to certify outstanding obligations before new appointments; Senate Bill 83 on human trafficking services after removing the age-expansion cost; Senate Bill 143 on bulletproof vests after shifting funding away from a direct state appropriation; and Senate Bill 450 on school safety assessments after an amendment limited implementation to available funds and resources. In each case, the committee’s actions focused on reducing or eliminating fiscal notes while keeping the bills moving forward.

Transcript Highlights:

• compensation by one additional day for parish elections and one additional day for presidential, regularly scheduled
• I hadn't asked the chairman to schedule it because it wasn't as important as this, although it was important
• We are on a time schedule and need to be in other committees.
• bad now, considering the level of poverty in our state, the domestic violence, the gun violence, the drugs

Bills: SB83 , SB135 , SB143 , SB155 , SB157 , SB202 , SB237 , SB261 , SB276 , SB295 , SB450 , SB465 , SB506 , HB1070

Committee: Senate Finance

Keywords: human trafficking, trafficking prevention, school safety, public schools, elementary and secondary education, charter schools, mandatory reporting, victim identification, victim services, child trafficking, sex trafficking, labor trafficking, commercial sexual activity, DCFS, Department of Children and Family Services, Louisiana State Police, governor's office of human trafficking prevention, counselor training, mental health professional, administrator training

Transcript Highlights:

• I know you will not have to be here next week, and it would be my expectation to work out a schedule
• time so that all of you will know the specific dates on when you have to be back in Tallahassee. a schedule
• Specifies that certified optometrists may administer the generic or therapeutic equivalent of drugs established
• Next week, we will publish a detailed schedule and appoint the members of the various conference committees

Bills: HJR 138 , HB 42 , HB 104 , HB 129 , HB 677 , HB 426 , HB 668 , HB 1699 , HB 2017 , HB 2128 , HB 2038 , HB 3783 , HB 3717 , HB 2316 , HB 3686 , HB 2563 , HB 3883 , HB 4021 , HB 2788 , HB 2663 , HB 3305 , HB 3173 , HB 3474 , HB 1105 , HB 3531 , HB 3490 , HB 3597 , HB 1295 , HB 3512 , HB 3010 , HB 3112 , HB 4215 , HB 3223 , HB 3464 , HB 3120 , HB 4214 , HB 4511 , HB 3704 , HB 4081 , HB 4783 , HB 4063 , HB 2783 , HB 4937 , HB 5085 , HB 2510 , HB 3426 , HB 4361 , HB 1169 , HB 2516 , HB 2347 , HB 4034 , HB 4700 , HB 3560 , HB 5150 , HB 3860 , HB 3146 , HB 3924 , HCR 98 , HCR 92 , HB 1520 , HB 1545 , HB 5265 , HB 1887 , HB 1914 , HB 2402 , HB 2306 , HB 2350 , HB 3000 , HB 3237 , HB 3326 , HB 3211 , HB 1056 , HB 2081 , HB 2187 , HB 3092 , HB 3308 , HB 3526 , HB 3750 , HB 4219 , HB 4230 , HB 4290 , HB 5238 , HB 4804 , HB 4749 , HB 245 , HB 1465 , HB 294 , HB 793 , HB 809 , HB 3928 , HB 334 , HB 2037 , HB 1973 , HB 285 , HB 4341 , HB 1043 , HB 1234 , HB 1193 , HB 1729 , HB 2498 , HB 1314 , HB 1353 , HB 3960 , HB 3923 , HB 2221 , HB 2517 , HB 2518 , HB 2213 , HB 5092 , HB 3748 , HB 5246 , HB 4344 , HB 1482 , HB 4044 , HB 2702 , HB 4264 , HB 2807 , HB 2898 , HB 3181 , HB 3250 , HB 2091 , HB 2115 , HB 2542 , HB 2768 , HB 3349 , HB 4406 , HB 1593 , HB 1899 , HB 3133 , HB 3133 , HB 4960 , HB 3214 , HB 2145 , HB 1201 , HB 5061 , SB 29 , SB 879 , SB 65 , SB 1745 , SB 412 , SB 412 , SB 1746 , SB 1238 , SB 1341 , SB 522 , SB 1532 , SB 1378 , SB 1062 , SB 2066 , SB 1963 , SB 2204 , SB 1366 , SB 2077 , SB 1967 , SB 1151 , HB 1618 , HB 2156 , HB 2615 , HB 2615 , HB 2349 , HB 1926 , HB 569 , HB 1762 , HB 38 , HJR 138 , HB 42 , HB 104 , HB 104 , HB 129 , HB 677 , HB 426 , HB 668 , HB 1699 , HB 2017 , HB 2128 , HB 2038 , HB 3783 , HB 3717 , HB 2316 , HB 3686 , HB 2563 , HB 3883 , HB 4021 , HB 2788 , HB 2663 , HB 2663 , HB 3305 , HB 3173 , HB 3474 , HB 1105 , HB 3531 , HB 3531 , HB 3490 , HB 3490 , HB 3597 , HB 1295 , HB 3512 , HB 3010 , HB 3112 , HB 4215 , HB 3223 , HB 3223 , HB 3464 , HB 3120 , HB 4214 , HB 4511 , HB 3704 , HB 4081 , HB 4783 , HB 4063 , HB 2783 , HB 4937 , HB 5085 , HB 2510 , HB 3426 , HB 4361 , HB 1169 , HB 2516 , HB 2347 , HB 4034 , HB 4700 , HB 3560 , HB 5150 , HB 3860 , HB 3146 , HB 3924 , HCR 98 , HCR 92

Transcript Highlights:

• The proposals being contemplated are already having effects as we plan our fall schedule.
• ongoing general fund support to cover the costs of recent legislation that requires the CSU to provide drug
• Given the lead time needed for both admission of new students and class schedules for fall, universities
• I've already made a 3% cut to this fall's schedule, which will eliminate 150 seats.

Transcript Highlights:

• As background, biological products are regulated by the federal Food and Drug Administration.
• products are manufactured, they cannot be replicated in the same way as traditional chemical-based drugs
• Under state and federal law, a pharmacist may substitute a brand-name drug or biological product with
• This is a benefit for individual patients to lower potential... ...drugs when appropriate.
• And if all the biosimilars are preferred drugs, it should yield a lower cost sharing.

Summary: The Health Care and Wellness Committee met on February 10 at 8:30 a.m. and heard two bills. On Engrossed Second Substitute Senate Bill 5594, staff explained that the bill would expand state policy on biosimilars by allowing health carriers to require patients to try a biosimilar before covering the equivalent brand drug starting in 2027, directing exchange plans to increase biosimilar utilization, and changing pharmacist substitution rules so substitution is generally allowed unless the prescriber says not to substitute. The prime sponsor, Sen. Harris, said the bill would lower costs and noted many other states already allow similar substitution. Supporters from health plans and generic/biosimilar manufacturers said biosimilars are safe, effective, and can save consumers and the system money, while a patient advocate raised concerns that the bill may not guarantee lower out-of-pocket costs at the pharmacy counter and suggested preferred formulary placement as a fix. AAM supported the bill with a technical amendment to place biosimilars in the same section as generics and interchangeable products, and the hearing on the bill was closed with no vote taken. The committee also heard Engrossed Senate Bill 5142 on Medicaid network adequacy for post-acute care. Staff said the bill would require the Health Care Authority to adopt network adequacy standards for nursing homes and inpatient rehabilitation facilities, considering community access, regional availability, timeliness, and federal Medicaid rules, with standards due by January 1, 2028 and implementation by July 1, 2028. Sen. Muzzall described it as a follow-up to last year’s bill that would create a pre-approved pathway for patients who are difficult to discharge because continuing care is hard to secure. Testimony from hospital and health system representatives strongly supported the bill, saying patients often remain in hospitals longer than medically necessary because of delays in finding skilled nursing or rehab placements and because single-case agreements are time-consuming and unpredictable, especially in rural areas. Public testimony on SB 5142 was then closed, and the meeting adjourned without any recorded votes or other action.

Transcript Highlights:

• We all are aware of the challenges that fentanyl and other drugs of abuse have caused our communities
• </c> with alcohol and drug problems. with alcohol and drug problems.
• </c> Hampshire's division of alcohol and drug Hampshire's division of alcohol and drug abuse<01:07:22.000
• </c><01:10:32.800><c> abuse</c><01:10:33.120><c> I</c> division of alcohol and drug abuse I division
• We have other partners: CVS Caremark for prescription drug, Delta Dental for dental coverage.

Committee: House Commerce and Consumer Affairs

Transcript Highlights:

• UNDER MEDICAID WE HAVE A TEAM OF PHARMACISTS AND PHYSICIANS WHO SET THE PREFERRED DRUG LIST AND WE GET
• REBATES ON THEM AND ON SPECIFIC DRUGS THAT THEY IMPROVE.
• YOU HAVE TO TAKE THAT MEDICATION AND THE SUBSEQUENT MEDICATIONS ON THE PREFERRED DRUG LIST UNTIL YOU
• IT WOULD REQUIRE THAT YOU DID NOT HAVE TO, THE PHYSICIAN DID NOT HAVE TO ORDER A DRUG ON THE PREFERRED
• DRUG LIST IF FOR DIFFERENT CONDITIONS, IF THERE IS NOT A DRUG ON THE PDL THAT IS AN ACCEPTABLE CLINICAL